UNSPSC 51413602: Bumepidil

This classification denotes a vasodilating agent with the molecular formula C12H17N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9FNZ7TFY4R, chemically known as 8-tert-butyl-7,8-dihydro-5-methyl-6h-pyrrolo(3,2-e)-s-triazolo(1,5-a)pyrimidine but generally known as bumepidil, which bears US NIH Compound Identifier 68813. European Medicines Agency schedules Bumepidil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05970MIG.

UNSPSC 51413602 Bumepidil (Commodity) covers emergency medications and pharmaceutical products acquired by state and local health and emergency services agencies. The code captures what state and local governments actually buy: emergency cardiac and hemodynamic medications supplied to fire rescue departments, state health agencies, and multi-state cooperative purchasing consortiums, typically in sealed-bid or RFP formats with strict quality, expiration, and compliance requirements tied to patient safety and regulatory standards.

State and local issuing bodies soliciting under this code include municipal fire rescue departments (City of Tampa), state health and human services commissions (Texas HHS), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance administering contracts across participating state and local government facilities). Recent activity shows the code active across Florida, Texas, Minnesota, and Oregon. Representative opportunities include the City of Tampa's sealed-bid solicitation (Bid No. 26-P-00188, due April 8, 2026) for Advanced Life Support Medications—370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials for Tampa Fire Rescue, with a contract value estimated at $40,000 and a Small Local Business Enterprise (SLBE) sheltered-market designation offering a 5 percent bid discount; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP (S1070000015802, due March 26, 2026) establishing multiple contracts for generic multi-source pharmaceuticals and OTC products across participating state and local government facilities, requiring vendors to supply through authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co.) with pricing weighted 75 percent on competitiveness and compliance with cGMP and DSCSA standards, contract term two years with optional extensions.